Sign In

Alexandra Goll

Senior Advisor TVM Capital GmbH and Managing Director BioPharma Advisory

Dr. Alexandra Goll is a seasoned professional with extensive managerial and operational expertise in the international pharmaceutical and biotechnology sector.

With a Ph.D. in Molecular Pharmacology from Philipps University in Marburg, Germany, Dr. Goll has a strong academic background in pharmacy and natural sciences.

She has held pivotal roles such as General Partner at TVM Capital, where she led strategic investment decisions, deal structuring, and exits in the life science and biotechnology venture capital fund.

Dr. Goll's entrepreneurial acumen extended to serving on the boards of various private and public companies in Europe and the USA, actively contributing to their strategic development and leveraging her industry insight and network.

Her investment instincts were evident in successful lead investments in companies like Actelion Ltd., Idenix Pharmaceuticals, Pharmasset Inc., and EUSA Pharma Ltd., demonstrating her keen eye for promising business opportunities.

In her early career, she excelled as the Global Business Leader for HIV and CMV at Roche Ltd., overseeing strategic marketing and business development for Virology and playing a key role in the clinical development and commercialization strategies of key products.

Dr. Goll's professional journey showcases her deep-rooted expertise in the pharmaceutical and biotechnology realms, marked by a blend of strategic leadership, investment foresight, and hands-on involvement in the growth of portfolio companies.

Recognized for her accomplishments, Dr. Goll was honored with a post-doctoral position supported by the Boehringer-Ingelheim Foundation and was elected among the top 40 most successful private equity females in 2008 by Private Equity News.

Alexandra Goll
Add to my network

Location

Munich Area, Germany